Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology

  • Marco Metra*
  • , Piotr Ponikowski
  • , Kenneth Dickstein
  • , John J. V. McMurray
  • , Antonello Gavazzi
  • , Claes-Hakan Bergh
  • , Alan G. Fraser
  • , Tiny Jaarsma
  • , Antonis Pitsis
  • , Paul Mohacsi
  • , Michael Boehm
  • , Stefan Anker
  • , Henry Dargie
  • , Dirk Brutsaert
  • , Michel Komajda
  • *Corresponding author for this work

    Research output: Contribution to journalReview articlepeer-review

    354 Citations (Scopus)

    Abstract

    Therapy has improved the survival of heart failure (HF) patients. However, many patients progress to advanced chronic HF (ACHF). We propose a practical clinical definition and describe the characteristics of this condition.

    Patients that are generally recognised as ACHF often exhibit the following characteristics: 1) severe symptoms (NYHA class III to IV); 2) episodes with clinical signs of fluid retention and/or peripheral hypoperfusion; 3) objective evidence of severe cardiac dysfunction, shown by at least one of the following: left ventricular ejection fraction <30%, pseudonormal or restrictive mitral inflow pattern at Doppler-echocardiography; high left and/or right ventricular filling pressures; elevated B-type natriuretic peptides; 4) severe impairment of functional capacity demonstrated by either inability to exercise, a 6-minute walk test distance <300 m or a peak oxygen uptake <12-14 ml/kg/min; 5) history of > 1 HF hospitalisation in the past 6 months; 6) presence of all the previous features despite optimal therapy. This definition identifies a group of patients with compromised quality of life, poor prognosis, and a high risk of clinical events. These patients deserve effective therapeutic options and should be potential targets for future clinical research initiatives. (C) 2007 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.

    Original languageEnglish
    Pages (from-to)684-694
    Number of pages11
    JournalEuropean Journal of Heart Failure
    Volume9
    Issue number6-7
    DOIs
    Publication statusPublished - 2007

    Keywords

    • heart failure
    • prognosis
    • treatment
    • CARDIAC-RESYNCHRONIZATION THERAPY
    • VENTRICULAR SYSTOLIC DYSFUNCTION
    • CONVERTING-ENZYME-INHIBITORS
    • IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    • CLINICAL-TRIALS UPDATE
    • 6-MINUTE WALK TEST
    • ONE-YEAR MORTALITY
    • BETA-BLOCKERS
    • OXYGEN-CONSUMPTION
    • COST-EFFECTIVENESS

    Fingerprint

    Dive into the research topics of 'Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology'. Together they form a unique fingerprint.

    Cite this